<DOC>
	<DOCNO>NCT00435487</DOCNO>
	<brief_summary>To compare efficacy safety dalteparin compare unfractionated heparin patient non ST elevation acute coronary syndrome plan undergo coronary intervention ( angioplasty bypass surgery )</brief_summary>
	<brief_title>Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome</brief_title>
	<detailed_description>The study prematurely discontinue November 30 , 2008 due delay meet pre-defined protocol recruitment milestone . There safety concern regard study decision terminate trial .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<criteria>Patients 18 year Ischemic pain 10 minute within 24 hour enrollment At least two follow three risk factor : Age 60 year ( 50 case diabetic ) , Raised cardiac enzyme level , abnormal ECG finding Contraindications use anticoagulant Active bleed abnormal coagulation test Ischemic stroke within last 6 month hemorrhagic stroke Lumbar spinal puncture within last 48 hour S creatinine level 2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Non-ST Elevation Acute Coronary Syndromes coronary intervention</keyword>
</DOC>